The North American synthetic biology market is anticipated to grow at a CAGR of 31.0% during the forecast period. The market growth is attributed to the increasing demand for bio-based products, rising R&D funding for synthetic biology, and increased investments by synthetic biology companies. Further, the growing support from the government, private institutions, and increasing R&D investments in the development of the drugs are other major factors that are expected to drive the ... Read more